H
HyVision System Inc
KOSDAQ:126700
HyVision System Inc
KOSDAQ:126700
Price:
17 630
KRW
1.61%
Market Cap:
224.4B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
HyVision System Inc
17630
+280 (+1.61%)
| 52 Week Range |
14 340
27 150
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
HyVision System Inc
Balance Sheet
Balance Sheet Decomposition
HyVision System Inc
HyVision System Inc
| Current Assets | 279.5B |
| Cash & Short-Term Investments | 85.3B |
| Receivables | 92.6B |
| Other Current Assets | 101.6B |
| Non-Current Assets | 97B |
| Long-Term Investments | 32.3B |
| PP&E | 52.4B |
| Intangibles | 4.3B |
| Other Non-Current Assets | 7.9B |
| Current Liabilities | 84.1B |
| Accounts Payable | 10.6B |
| Accrued Liabilities | 17.3B |
| Short-Term Debt | 2.7B |
| Other Current Liabilities | 53.5B |
| Non-Current Liabilities | 33.6B |
| Long-Term Debt | 727.4m |
| Other Non-Current Liabilities | 32.9B |
Balance Sheet
HyVision System Inc
HyVision System Inc
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
7 754
|
16 811
|
12 137
|
29 949
|
50 439
|
18 543
|
35 612
|
45 844
|
59 575
|
58 836
|
|
| Cash |
5
|
4
|
5
|
7
|
7
|
9
|
11
|
10
|
8
|
16
|
|
| Cash Equivalents |
7 749
|
16 807
|
12 132
|
29 942
|
50 432
|
18 534
|
35 601
|
45 834
|
59 567
|
58 820
|
|
| Short-Term Investments |
21 755
|
7 595
|
25 136
|
24 132
|
7 205
|
9 822
|
3 820
|
48 199
|
6 263
|
2 924
|
|
| Total Receivables |
26 509
|
26 500
|
24 281
|
21 123
|
19 453
|
38 506
|
41 992
|
45 926
|
82 615
|
95 284
|
|
| Accounts Receivables |
25 980
|
25 414
|
23 904
|
19 882
|
18 346
|
36 403
|
40 115
|
43 668
|
69 833
|
90 406
|
|
| Other Receivables |
529
|
1 086
|
377
|
1 241
|
1 107
|
2 103
|
1 877
|
2 258
|
12 783
|
4 878
|
|
| Inventory |
6 697
|
9 236
|
12 229
|
35 525
|
28 156
|
31 630
|
17 313
|
24 863
|
62 329
|
101 834
|
|
| Other Current Assets |
88
|
1 241
|
736
|
4 528
|
2 879
|
5 147
|
5 264
|
5 809
|
12 472
|
7 222
|
|
| Total Current Assets |
62 803
|
61 383
|
74 519
|
115 257
|
108 131
|
103 647
|
104 002
|
170 641
|
223 255
|
266 099
|
|
| PP&E Net |
11 994
|
12 661
|
11 989
|
26 850
|
44 496
|
46 312
|
45 772
|
46 171
|
50 213
|
49 527
|
|
| PP&E Gross |
11 994
|
12 661
|
11 989
|
26 850
|
44 496
|
46 312
|
45 772
|
46 171
|
50 213
|
49 527
|
|
| Accumulated Depreciation |
1 339
|
1 961
|
2 705
|
3 252
|
3 823
|
5 265
|
6 959
|
8 646
|
10 164
|
11 765
|
|
| Intangible Assets |
1 465
|
7 994
|
4 171
|
924
|
975
|
1 236
|
1 270
|
1 811
|
1 746
|
3 655
|
|
| Goodwill |
0
|
0
|
0
|
0
|
958
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
1 666
|
0
|
0
|
0
|
0
|
0
|
64
|
5
|
|
| Long-Term Investments |
1 427
|
4 155
|
5 040
|
9 542
|
8 903
|
10 416
|
15 067
|
23 269
|
27 267
|
31 672
|
|
| Other Long-Term Assets |
1 154
|
2 570
|
1 891
|
3 726
|
4 052
|
4 240
|
2 322
|
1 790
|
6 824
|
9 294
|
|
| Other Assets |
0
|
0
|
0
|
0
|
958
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
78 844
N/A
|
88 763
+13%
|
99 277
+12%
|
156 299
+57%
|
167 516
+7%
|
165 852
-1%
|
168 432
+2%
|
243 682
+45%
|
309 369
+27%
|
360 252
+16%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
7 564
|
5 558
|
11 624
|
22 335
|
7 612
|
14 589
|
6 761
|
10 603
|
33 859
|
21 427
|
|
| Accrued Liabilities |
899
|
3 100
|
4 693
|
12 969
|
16 729
|
10 749
|
13 037
|
25 358
|
27 861
|
32 752
|
|
| Short-Term Debt |
300
|
300
|
0
|
13 000
|
13 186
|
6 838
|
5 826
|
5 000
|
1 000
|
1 754
|
|
| Current Portion of Long-Term Debt |
667
|
667
|
0
|
0
|
703
|
183
|
162
|
336
|
453
|
432
|
|
| Other Current Liabilities |
693
|
2 224
|
3 217
|
10 343
|
8 630
|
7 276
|
6 943
|
14 388
|
21 367
|
36 948
|
|
| Total Current Liabilities |
10 122
|
11 850
|
19 533
|
58 647
|
46 861
|
39 635
|
32 730
|
55 685
|
84 540
|
93 314
|
|
| Long-Term Debt |
667
|
664
|
0
|
0
|
0
|
172
|
106
|
147
|
504
|
702
|
|
| Minority Interest |
0
|
365
|
0
|
315
|
3 529
|
1 195
|
1 596
|
6 923
|
22 799
|
29 651
|
|
| Other Liabilities |
766
|
78
|
144
|
253
|
168
|
871
|
1 529
|
1 205
|
1 196
|
1 338
|
|
| Total Liabilities |
11 554
N/A
|
12 957
+12%
|
19 677
+52%
|
59 215
+201%
|
50 558
-15%
|
41 872
-17%
|
35 960
-14%
|
63 960
+78%
|
109 039
+70%
|
125 005
+15%
|
|
| Equity | |||||||||||
| Common Stock |
7 471
|
7 471
|
7 471
|
7 471
|
7 471
|
7 471
|
7 471
|
11 186
|
19 313
|
19 216
|
|
| Retained Earnings |
46 835
|
55 790
|
59 899
|
80 140
|
101 240
|
107 770
|
117 301
|
159 977
|
182 778
|
226 048
|
|
| Additional Paid In Capital |
19 555
|
19 851
|
19 555
|
19 555
|
19 573
|
19 605
|
19 610
|
19 555
|
19 555
|
19 555
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
45
|
65
|
1 724
|
1 459
|
537
|
1 076
|
68
|
155
|
|
| Treasury Stock |
6 310
|
6 904
|
6 904
|
9 691
|
12 587
|
12 377
|
12 590
|
12 224
|
21 496
|
30 349
|
|
| Other Equity |
262
|
402
|
466
|
455
|
465
|
52
|
143
|
152
|
248
|
623
|
|
| Total Equity |
67 289
N/A
|
75 806
+13%
|
79 601
+5%
|
97 084
+22%
|
116 957
+20%
|
123 980
+6%
|
132 472
+7%
|
179 722
+36%
|
200 330
+11%
|
235 246
+17%
|
|
| Total Liabilities & Equity |
78 844
N/A
|
88 763
+13%
|
99 277
+12%
|
156 299
+57%
|
167 516
+7%
|
165 852
-1%
|
168 432
+2%
|
243 682
+45%
|
309 369
+27%
|
360 252
+16%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
13
|
13
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
